PPT-Advanced Imaging for Early Prostate Cancer Staging

When to Image Based on Choosing Wisely and ACR Appropriateness Criteria What Is RSCAN 2 C ollaborative activity for referring clinicians and radiologists to improve patient . This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a . Kentucky Cancer Registry. Overview. Anatomy. Common Terms. Changes . in . T,N,M Staging from AJCC 6. th . edition to 7. th. edition. Elements of . Staging: TX-T4 Clinical and Pathological, NX-N1. , and . Zehra Nihal Dolgun, Ahmet Salih . Altintas. , . Cihan . Inan. , Petek . Balkanli. Trakya University. ,. Faculty. of . Medicine. ,. . Department of Obstetrics and Gynecology, . Edirne. . Uterine. c. ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES Samuel Denmeade, MD Professor of Oncology, Urology and Pharmacology The Johns Hopkins University School of Medicine Castrate-sensitive Non-Metastatic CÉSAR DAVID VERA-DONOSO. Department. of . Urology. WHO IS IN THE LINE OF FIRE?. WE NEED TO COLLABORATE IN MANY FIELDS. WE NEED RELIABLE IMAGES TO TAKE DECISIONS. INCIDENCE. EUROPE. In Europe, . PCa. Maurizio Conti. Siemens Healthcare Molecular Imaging, Knoxville, Tennessee, USA. Mediterranean Thematic Workshops in Advanced Molecular Imaging. Alghero. , September 2-7, 2014. index. . motivation & introduction. A Resident’s Primer. Presented as an education exhibit at the 2014 RSNA Annual Meeting – OBE117.. All authors have disclosed no relevant relationships.. Anish . Raithatha. , BSc, MBBS,. 1*. . Ioanna. A Resident’s Primer. Presented as an education exhibit at the 2014 RSNA Annual Meeting – OBE117.. All authors have disclosed no relevant relationships.. Anish . Raithatha. , BSc, MBBS,. 1*. . Ioanna. 367 Rectal cancer is prone to local recurrence and systemic metastasis. However, owing to improvements in TNM staging and treatment, diologist awareness of the key rectal cancer TNM staging features, No significant relationship exists between the authors and the compa-nies/organizations whose products or services may be referenced inthis article. Abbreviations used in this paper:CT = computed tomo . By Dr. . Hiralal. . Chaudhari. M.B.B.S., D.N.B. (General Surgery). D.N.B. (Urology). Foundation Medicine. ctDNA. is good information for somatic mutations in . mCRPC. when biopsy is not possible. lots of other data on the importance of CTCs as predictive. 93% concordance for BRCA1/2 for tissue and liquid biopsy – . Dr Marie-Pier St-Laurent, MD, FRCSC. Urologic-Oncology fellow, UBC. Research scientist, Vancouver Prostate Centre. Honorarium: Bayer, PCSC. As a urologist, I am biased towards prostate cancer screening.. Session Objectives. Updates of the Status of Research Effort. Evaluation of Biomarker Development Status. Imaging and Urine Testing to Enhance Prostate Cancer Detection. Martin . Sanda. , M.D., Emory University. CVC.